GH - Guardant Health, Inc.
NEXT EARNINGS:
Apr 29, 2026
EPS Est: $-0.47
|
Rev Est: $279.6M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$130.27
DETAILS
HIGH:
$175.00
LOW:
$75.00
MEDIAN:
$130.00
CONSENSUS:
$130.27
UPSIDE:
36.55%
Market Cap:
12.39B
Volume:
1,917,426
Avg Volume:
2,088,518
52 Week Range:
34.88-120.74
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.65
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
1,999
IPO Date:
2018-10-04
EPS (TTM):
-3.32
P/E Ratio:
-30.76
Revenue (TTM):
982.02M
Total Assets:
2.01B
Total Debt:
1.68B
Cash & Equiv:
378.20M
Rev Growth (5Y):
27.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-25.5%
Debt/Equity:
-16.94
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $-0.50 | $-0.42 | -19.0% | $281.3M | $275.8M | +2.0% |
| 2025-10-29 | $-0.39 | $-0.48 | +18.7% | $265.2M | $267.6M | -0.9% |
| 2025-07-30 | $-0.44 | $-0.52 | +15.4% | $232.1M | $235.7M | -1.5% |
| 2025-04-30 | $-0.49 | $-0.61 | +19.7% | $203.5M | $211.4M | -3.8% |
| 2025-02-20 | $-0.62 | $-0.75 | +17.3% | $201.8M | $192.5M | +4.8% |
| 2024-11-06 | $-0.45 | $-0.55 | +18.2% | $191.5M | $189.0M | +1.3% |
| 2024-08-07 | $-0.48 | $-0.57 | +15.8% | $177.2M | $162.7M | +8.9% |
| 2024-05-09 | $-0.46 | $-0.72 | +36.1% | $168.5M | $150.7M | +11.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 982.02M | 739.02M | 563.95M | 449.54M | 373.65M | 286.73M | 214.38M | 90.64M | 49.84M | 25.25M |
| Net Income | (416.28M) | (436.37M) | (479.45M) | (654.59M) | (405.67M) | (253.78M) | (75.65M) | (85.06M) | (83.22M) | (46.14M) |
| EPS | -3.32 | -3.56 | -4.28 | -6.41 | -3.80 | -2.53 | -0.75 | -1.00 | -1.18 | -3.49 |
| Total Assets | 2.01B | 1.49B | 1.79B | 1.61B | 2.20B | 2.27B | 962.53M | 587.40M | 342.94M | 116.56M |
| Total Debt | 1.68B | 1.34B | 1.35B | 1.37B | 1.37B | 854.49M | 40.40M | 0 | 659,000 | 17.04M |
| Cash & Equivalents | 378.20M | 525.54M | 1.13B | 141.65M | 492.20M | 832.98M | 143.23M | 140.54M | 72.28M | 33.59M |
| Operating Cash Flow | (184.76M) | (239.86M) | (324.98M) | (309.46M) | (209.02M) | (103.93M) | (47.13M) | (72.19M) | (72.23M) | (36.71M) |
| Free Cash Flow | (233.07M) | (274.94M) | (345.46M) | (386.92M) | (284.05M) | (157.99M) | (68.42M) | (92.39M) | (81.22M) | (38.48M) |
| FCF per Share | -1.86 | -2.24 | -3.08 | -3.79 | -2.80 | -1.62 | -0.76 | -1.09 | -1.15 | -2.91 |
| Book Value | (99.31M) | (139.65M) | 158.68M | 60.18M | 645.00M | 1.30B | 798.39M | 483.15M | 308.61M | 79.70M |
| Cash & ST Investments | 1.20B | 839.98M | 1.17B | 1.01B | 932.75M | 1.79B | 522.80M | 418.96M | 221.32M | 95.26M |
| ROC Equity | N/A | N/A | -3.02 | -10.88 | -0.63 | -0.20 | -0.09 | -0.18 | -0.27 | -0.58 |